Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zevra Therapeutics (ZVRA) Prepaid Assets (2016 - 2025)

Zevra Therapeutics' Prepaid Assets history spans 11 years, with the latest figure at $7.0 million for Q4 2025.

  • For Q4 2025, Prepaid Assets rose 72.7% year-over-year to $7.0 million; the TTM value through Dec 2025 reached $7.0 million, up 72.7%, while the annual FY2025 figure was $7.0 million, 72.7% up from the prior year.
  • Prepaid Assets reached $7.0 million in Q4 2025 per ZVRA's latest filing, down from $7.4 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $7.4 million in Q3 2025 to a low of -$426000.0 in Q2 2022.
  • Average Prepaid Assets over 5 years is $2.5 million, with a median of $1.9 million recorded in 2021.
  • Peak YoY movement for Prepaid Assets: tumbled 121.32% in 2022, then skyrocketed 574.88% in 2023.
  • A 5-year view of Prepaid Assets shows it stood at $1.2 million in 2021, then soared by 42.81% to $1.7 million in 2022, then plummeted by 30.57% to $1.2 million in 2023, then soared by 245.73% to $4.1 million in 2024, then surged by 72.7% to $7.0 million in 2025.
  • Per Business Quant, the three most recent readings for ZVRA's Prepaid Assets are $7.0 million (Q4 2025), $7.4 million (Q3 2025), and $4.4 million (Q2 2025).